Clinical Trials in the EU / 2025-523409-13-00
Authorised, recruiting
Phase I
A study to find how safe different doses of LFD-200 are and how it works in both healthy people and people with moderate to severe rheumatoid arthritis
2025-523409-13-00 · tracked via the Priya Life Science EU tracker
Condition studied
Moderate to Severe Rheumatoid Arthritis
Eligibility
Official registry record
This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View 2025-523409-13-00 on CTIS ↗ ← All trials in the EU